TC
Turner Christopher Durant
Directeur Médical
OtherM
内部人交易记录
高级管理人员基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the complete record of transactions filed by Turner Christopher Durant, Directeur Médical. Officer active across 1 company, notably Nuvalent, Inc.. Aggregated, 12 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €71k. Activity tracked since 17 May 2022. The latest transaction was disclosed on 15 July 2026 (U). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Turner Christopher Durant
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
31,530 股@ US$124.00Class A Common StockSEC:0001193125-26-305073:0
41,100 股Class A Common Stock - Restricted Stock UnitsSEC:0001193125-26-305073:1
14,350 股0Class A Common Stock - Performance Stock UnitsSEC:0001193125-26-305073:2
14,350 股Class A Common Stock - Performance Stock UnitsSEC:0001193125-26-305073:3
871 股@ US$96.0623.8% 占其流量Class A Common StockSEC:0001193125-26-006571:0
18,750 股0Class A Common StockSEC:0000950170-25-003490:0
33,300 股0Class A Common StockSEC:0000950170-24-003392:0
7,995 股@ US$6.8923.0% 占其流量Class A Common StockSEC:0001209191-23-052349:0
2,365 股@ US$6.896.4% 占其流量Class A Common StockSEC:0001209191-23-043700:0
100 股@ US$6.890.3% 占其流量Class A Common StockSEC:0001209191-23-043226:0
10,235 股@ US$6.8928.8% 占其流量Class A Common StockSEC:0001209191-23-035126:0
14,513 股@ US$6.890.0012% mcap100.0% 占其流量Class A Common StockSEC:0001209191-22-030530:0
About Turner Christopher Durant
Turner Christopher Durant is the Chief Medical Officer at Nuvalent, Inc. He is responsible for leading the company's medical and clinical initiatives. His role is crucial in ensuring compliance with medical standards and guiding product development.